Research Nester published a report titled “Western Europe Intraoperative Neuromonitoring (IONM) Electromyograph (EMG) Devices Market: Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the Western Europe intraoperative neuromonitoring (IONM) electromyograph (EMG) devices market in terms of market segmentation by device type, procedure, EMG types, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The Western Europe intraoperative neuromonitoring (IONM) electromyograph (EMG) devices market is anticipated to grow with a CAGR of 7.4% during 2020-2029. The market is segmented on the basis of end-user into hospital, ambulatory surgery centers, and others, out of which, the hospital segment is anticipated to garner the largest market revenue of USD 81428 Thousand by the end of 2029 by growing with a CAGR of 7.5% during the forecast period.

The Western Europe intraoperative neuromonitoring (IONM) electromyograph (EMG) devices market is estimated to garner a revenue of USD 140650 Thousand by the end of 2029, up from a revenue of USD 73902.2 Thousand in 2020. Growing utilization of IONM in various surgeries, backed by its increasing efficacy, followed by the growing awareness about the use of the medical tool, and the increasing incidences of thyroid cancer, where IONM devices are used for surgery, are some of the major factors anticipated to drive the market growth during the forecast period.

Geographically, the Western Europe intraoperative neuromonitoring (IONM) electromyograph (EMG) devices market is segmented into Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom, and the Rest of Western Europe countries, out of which, the market in Germany is anticipated to hold the highest market share throughout the forecast period, and also reach a revenue of USD 26306.7 Thousand by the end of 2029, up from USD 12267.7 Thousand in the year 2020.

Increasing Incidences of Thyroid Cancer

In Europe, the number of new cases of thyroid cancer amongst males between the age group of 0 to over 85 years old, according to the statistics by the International Agency for Research on Cancer, reached 19.3 Thousands in 2020, and is further projected to grow to 20.1 Thousands by the end of 2040.

Backed by the growing cases of thyroid cancer in Europe, healthcare practitioners are increasingly using intraoperative neuromonitoring (IONM) devices for the surgery of the cancer disease. With the recent advancements in healthcare devices, IONM devices have witnessed an increase in its efficacy. Moreover, utilization of these devices lowers the risk of damage to the nervous system during the thyroid or parathyroid surgeries. Such factors are therefore anticipated to drive the growth of the Western Europe intraoperative neuromonitoring (IONM) electromyograph (EMG) devices market during the forecast period.

However, the high price of IONM is expected to operate as key restraint to the growth of Western Europe intraoperative neuromonitoring (IONM) electromyograph (EMG) devices market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the Western Europe intraoperative neuromonitoring (IONM) electromyograph (EMG) devices market which includes company profiling of inomed Medizintechnik GmbH, Dr. Langer Medical GmbH, Neurosign, Medtronic plc, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the Western Europe intraoperative neuromonitoring (IONM) electromyograph (EMG) devices market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.